Karyopharm Therapeutics 2024 HC Wainwright Conference Presentation

Loading viewer...

conference

Format: PDF conference

Karyopharm Therapeutics presented at the HC Wainwright 26th Annual Global Investment Conference in September 2024, discussing selinexor (XPOVIO) development and commercialization. The presentation covers the company's refinancing transactions, 2024 financial guidance, and clinical development plans for selinexor across multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma.

Browse all conferences →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Karyopharm Therapeutics Inc.

View all →

Karyopharm Therapeutics 2022 Cancer Therapy Investor Presentation

investor_presentation

35 Pages

Karyopharm Therapeutics ASH 2020 Investor Presentation

conference

Similar conferences from other companies

Browse all →

Visteon Corporation 2016 Raymond James Technology Conference

conference

22 Pages

Visteon Corporation

Raymond James Banking Conference July 2024 Financial Institutions

conference